NASDAQ:COSM - Nasdaq - US2214133058 - Common Stock - Currency: USD
0.6165
-0.01 (-1.89%)
The current stock price of COSM is 0.6165 USD. In the past month the price decreased by -21.84%. In the past year, price decreased by -19.4%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
MCK | MCKESSON CORP | 20.5 | 74.91B | ||
COR | CENCORA INC | 16.99 | 46.77B | ||
CAH | CARDINAL HEALTH INC | 16.44 | 30.69B | ||
HSIC | HENRY SCHEIN INC | 18.35 | 9.59B | ||
PDCO | PATTERSON COS INC | 14.66 | 2.74B | ||
AHCO | ADAPTHEALTH CORP | N/A | 1.14B | ||
AHG | AKSO HEALTH GROUP | N/A | 518.47M | ||
OMI | OWENS & MINOR INC | 3.75 | 479.62M | ||
VRAX | VIRAX BIOLABS GROUP LTD | N/A | 8.12M | ||
ATPC | AGAPE ATP CORP | N/A | 3.73M |
Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. The company is headquartered in Chicago, Illinois and currently employs 123 full-time employees. The company went IPO on 2010-05-19. The firm owns a portfolio of pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe and C-Sept. Through its subsidiary, Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. The company distributes a line of pharmaceuticals and Para pharmaceuticals, including branded generics and over the counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. The company is also engaged in the research and development (R&D) of patented nutraceuticals and specialized root extracts as well as in the R&D of complex generics and OTC products. The company offers Cloudscreen, a multimodal platform specialized in drug repurposing, a process of uncovering new target proteins. The company is also specialized in the storage and distribution of pharmaceutical and Para pharmaceutical goods.
COSMOS HEALTH INC
141 W. Jackson Blvd, Suite 4236
Chicago ILLINOIS US
Employees: 123
Company Website: https://www.cosmosholdingsinc.com/
Investor Relations: https://investors.cosmoshealthinc.com/
Phone: 13125363102
The current stock price of COSM is 0.6165 USD. The price decreased by -1.89% in the last trading session.
The exchange symbol of COSMOS HEALTH INC is COSM and it is listed on the Nasdaq exchange.
COSM stock is listed on the Nasdaq exchange.
7 analysts have analysed COSM and the average price target is 3.06 USD. This implies a price increase of 396.35% is expected in the next year compared to the current price of 0.6165. Check the COSMOS HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
COSMOS HEALTH INC (COSM) has a market capitalization of 14.34M USD. This makes COSM a Nano Cap stock.
COSMOS HEALTH INC (COSM) currently has 123 employees.
COSMOS HEALTH INC (COSM) has a support level at 0.61 and a resistance level at 0.7. Check the full technical report for a detailed analysis of COSM support and resistance levels.
The Revenue of COSMOS HEALTH INC (COSM) is expected to grow by 6.66% in the next year. Check the estimates tab for more information on the COSM EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
COSM does not pay a dividend.
COSMOS HEALTH INC (COSM) will report earnings on 2025-08-04.
COSMOS HEALTH INC (COSM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.23).
The outstanding short interest for COSMOS HEALTH INC (COSM) is 2.83% of its float. Check the ownership tab for more information on the COSM short interest.
ChartMill assigns a fundamental rating of 2 / 10 to COSM. COSM has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months COSM reported a non-GAAP Earnings per Share(EPS) of -2.23. The EPS increased by 71.84% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -52.41% | ||
ROE | -96.67% | ||
Debt/Equity | 0.25 |
ChartMill assigns a Buy % Consensus number of 83% to COSM. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of -21.87% and a revenue growth 6.66% for COSM